RESUMEN
Anterior mediastinal mass presents an airway challenge due to its relative size in a paediatric chest and its invasion and compression of the surrounding structures. We present a case of a toddler with airway obstruction secondary to an anterior mediastinal mass. We describe how the use of an armoured endotracheal tube helped with ventilation while waiting for steroids and chemotherapy to reduce the tumour size and compression.
Asunto(s)
Obstrucción de las Vías Aéreas , Intubación Intratraqueal , Humanos , Niño , Preescolar , Obstrucción de las Vías Aéreas/etiología , Obstrucción de las Vías Aéreas/cirugíaRESUMEN
Broad-spectrum antimicrobial use during the treatment of critical illness influences gastrointestinal fermentation endpoints, host immune response and metabolic activity including the conversion of primary to secondary bile acids. We previously observed reduced fermentation capacity in the faecal microbiota of critically ill children upon hospital admission. Here, we further explore the timecourse of the relationship between the microbiome and bile acid profile in faecal samples collected from critically ill children. The microbiome was assayed by sequencing of the 16S rRNA gene, and faecal water bile acids were measured by liquid chromatography mass spectrometry. In comparison to admission faecal samples, members of the Lachnospiraceae recovered during the late-acute phase (days 8-10) of hospitalisation. Patients with infections had a lower proportion of Lachnospiraceae in their gut microbiota than controls and patients with primary admitting diagnoses. Keystone species linked to ecological recovery were observed to decline with the length of PICU admission. These species were further suppressed in patients with systemic infection, respiratory failure, and undergoing surgery. Bile acid composition recovers quickly after intervention for critical illness which may be aided by the compositional shift in Lachnospiraceae. Our findings suggest gut microbiota recovery can be readily assessed via measurement of faecal bile acids.
Asunto(s)
Microbioma Gastrointestinal , Ácidos y Sales Biliares/análisis , Niño , Clostridiales/genética , Enfermedad Crítica , Heces/química , Microbioma Gastrointestinal/fisiología , Humanos , ARN Ribosómico 16S/análisis , ARN Ribosómico 16S/genéticaAsunto(s)
Quemaduras Químicas/etiología , Cáusticos/efectos adversos , Glotis/efectos de los fármacos , Enfermedades de la Laringe/inducido químicamente , Hidróxido de Sodio/efectos adversos , Analgésicos/administración & dosificación , Quemaduras Químicas/diagnóstico , Quemaduras Químicas/terapia , Sedación Consciente , Glotis/patología , Humanos , Lactante , Enfermedades de la Laringe/diagnóstico , Enfermedades de la Laringe/terapia , Laringoscopía , Masculino , Traqueostomía , Pliegues Vocales/efectos de los fármacos , Pliegues Vocales/patologíaRESUMEN
Most paediatricians will have faced the challenge of managing respiratory problems in the child with severe neurological impairment. These children are under-represented in clinical trials, and data is therefore often extrapolated from other groups, for example children with cystic fibrosis. This means that robust evidence for respiratory management in children with severe neurological impairment is often lacking. Here we have attempted to piece together the existing evidence to provide a rational approach to the management of respiratory problems in children with severe neurological impairment. We also hope to highlight areas of uncertainty, in order to aid honest discussions with families. The respiratory management of the child with neuromuscular disease is beyond the scope of this article.